Global Drug Eluting Implant Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Drug Eluting Implant Industry Forecast” looks at past sales and reviews total world Drug Eluting Implant sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Eluting Implant sales for 2023 through 2029. With Drug Eluting Implant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Eluting Implant industry.
This Insight Report provides a comprehensive analysis of the global Drug Eluting Implant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Eluting Implant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Drug Eluting Implant market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Eluting Implant and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Eluting Implant.
The global Drug Eluting Implant market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drug Eluting Implant is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drug Eluting Implant is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drug Eluting Implant is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drug Eluting Implant players cover Boston Scientific, Medtronic, Abbott, Lepu Medical, B. Braun Melsungen, MicroPort Scientific, Cook Medical, Terumo and Biosensors International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Eluting Implant market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Drug Eluting Implant market?
What factors are driving Drug Eluting Implant market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug Eluting Implant market opportunities vary by end market size?
How does Drug Eluting Implant break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Drug Eluting Implant Industry Forecast” looks at past sales and reviews total world Drug Eluting Implant sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug Eluting Implant sales for 2023 through 2029. With Drug Eluting Implant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Eluting Implant industry.
This Insight Report provides a comprehensive analysis of the global Drug Eluting Implant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Eluting Implant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Drug Eluting Implant market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Eluting Implant and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Eluting Implant.
The global Drug Eluting Implant market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drug Eluting Implant is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drug Eluting Implant is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drug Eluting Implant is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drug Eluting Implant players cover Boston Scientific, Medtronic, Abbott, Lepu Medical, B. Braun Melsungen, MicroPort Scientific, Cook Medical, Terumo and Biosensors International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Eluting Implant market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Rapamycin Eluting Implant
- Paclitaxel Eluting Implant
- Everolimus Eluting Implant
- Others
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boston Scientific
- Medtronic
- Abbott
- Lepu Medical
- B. Braun Melsungen
- MicroPort Scientific
- Cook Medical
- Terumo
- Biosensors International
- Balton
- AlviMedica Medical Technologies
- Biotronik
- Shandong JW Medical
- Sino Medical
- Beijing AMSINO
What is the 10-year outlook for the global Drug Eluting Implant market?
What factors are driving Drug Eluting Implant market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug Eluting Implant market opportunities vary by end market size?
How does Drug Eluting Implant break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Eluting Implant Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Drug Eluting Implant by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Drug Eluting Implant by Country/Region, 2018, 2022 & 2029
2.2 Drug Eluting Implant Segment by Type
2.2.1 Rapamycin Eluting Implant
2.2.2 Paclitaxel Eluting Implant
2.2.3 Everolimus Eluting Implant
2.2.4 Others
2.3 Drug Eluting Implant Sales by Type
2.3.1 Global Drug Eluting Implant Sales Market Share by Type (2018-2023)
2.3.2 Global Drug Eluting Implant Revenue and Market Share by Type (2018-2023)
2.3.3 Global Drug Eluting Implant Sale Price by Type (2018-2023)
2.4 Drug Eluting Implant Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Centers
2.4.4 Others
2.5 Drug Eluting Implant Sales by Application
2.5.1 Global Drug Eluting Implant Sale Market Share by Application (2018-2023)
2.5.2 Global Drug Eluting Implant Revenue and Market Share by Application (2018-2023)
2.5.3 Global Drug Eluting Implant Sale Price by Application (2018-2023)
3 GLOBAL DRUG ELUTING IMPLANT BY COMPANY
3.1 Global Drug Eluting Implant Breakdown Data by Company
3.1.1 Global Drug Eluting Implant Annual Sales by Company (2018-2023)
3.1.2 Global Drug Eluting Implant Sales Market Share by Company (2018-2023)
3.2 Global Drug Eluting Implant Annual Revenue by Company (2018-2023)
3.2.1 Global Drug Eluting Implant Revenue by Company (2018-2023)
3.2.2 Global Drug Eluting Implant Revenue Market Share by Company (2018-2023)
3.3 Global Drug Eluting Implant Sale Price by Company
3.4 Key Manufacturers Drug Eluting Implant Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug Eluting Implant Product Location Distribution
3.4.2 Players Drug Eluting Implant Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG ELUTING IMPLANT BY GEOGRAPHIC REGION
4.1 World Historic Drug Eluting Implant Market Size by Geographic Region (2018-2023)
4.1.1 Global Drug Eluting Implant Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Drug Eluting Implant Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Drug Eluting Implant Market Size by Country/Region (2018-2023)
4.2.1 Global Drug Eluting Implant Annual Sales by Country/Region (2018-2023)
4.2.2 Global Drug Eluting Implant Annual Revenue by Country/Region (2018-2023)
4.3 Americas Drug Eluting Implant Sales Growth
4.4 APAC Drug Eluting Implant Sales Growth
4.5 Europe Drug Eluting Implant Sales Growth
4.6 Middle East & Africa Drug Eluting Implant Sales Growth
5 AMERICAS
5.1 Americas Drug Eluting Implant Sales by Country
5.1.1 Americas Drug Eluting Implant Sales by Country (2018-2023)
5.1.2 Americas Drug Eluting Implant Revenue by Country (2018-2023)
5.2 Americas Drug Eluting Implant Sales by Type
5.3 Americas Drug Eluting Implant Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Eluting Implant Sales by Region
6.1.1 APAC Drug Eluting Implant Sales by Region (2018-2023)
6.1.2 APAC Drug Eluting Implant Revenue by Region (2018-2023)
6.2 APAC Drug Eluting Implant Sales by Type
6.3 APAC Drug Eluting Implant Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug Eluting Implant by Country
7.1.1 Europe Drug Eluting Implant Sales by Country (2018-2023)
7.1.2 Europe Drug Eluting Implant Revenue by Country (2018-2023)
7.2 Europe Drug Eluting Implant Sales by Type
7.3 Europe Drug Eluting Implant Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Eluting Implant by Country
8.1.1 Middle East & Africa Drug Eluting Implant Sales by Country (2018-2023)
8.1.2 Middle East & Africa Drug Eluting Implant Revenue by Country (2018-2023)
8.2 Middle East & Africa Drug Eluting Implant Sales by Type
8.3 Middle East & Africa Drug Eluting Implant Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Eluting Implant
10.3 Manufacturing Process Analysis of Drug Eluting Implant
10.4 Industry Chain Structure of Drug Eluting Implant
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug Eluting Implant Distributors
11.3 Drug Eluting Implant Customer
12 WORLD FORECAST REVIEW FOR DRUG ELUTING IMPLANT BY GEOGRAPHIC REGION
12.1 Global Drug Eluting Implant Market Size Forecast by Region
12.1.1 Global Drug Eluting Implant Forecast by Region (2024-2029)
12.1.2 Global Drug Eluting Implant Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug Eluting Implant Forecast by Type
12.7 Global Drug Eluting Implant Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Drug Eluting Implant Product Portfolios and Specifications
13.1.3 Boston Scientific Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Drug Eluting Implant Product Portfolios and Specifications
13.2.3 Medtronic Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Drug Eluting Implant Product Portfolios and Specifications
13.3.3 Abbott Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Lepu Medical
13.4.1 Lepu Medical Company Information
13.4.2 Lepu Medical Drug Eluting Implant Product Portfolios and Specifications
13.4.3 Lepu Medical Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lepu Medical Main Business Overview
13.4.5 Lepu Medical Latest Developments
13.5 B. Braun Melsungen
13.5.1 B. Braun Melsungen Company Information
13.5.2 B. Braun Melsungen Drug Eluting Implant Product Portfolios and Specifications
13.5.3 B. Braun Melsungen Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 B. Braun Melsungen Main Business Overview
13.5.5 B. Braun Melsungen Latest Developments
13.6 MicroPort Scientific
13.6.1 MicroPort Scientific Company Information
13.6.2 MicroPort Scientific Drug Eluting Implant Product Portfolios and Specifications
13.6.3 MicroPort Scientific Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 MicroPort Scientific Main Business Overview
13.6.5 MicroPort Scientific Latest Developments
13.7 Cook Medical
13.7.1 Cook Medical Company Information
13.7.2 Cook Medical Drug Eluting Implant Product Portfolios and Specifications
13.7.3 Cook Medical Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Cook Medical Main Business Overview
13.7.5 Cook Medical Latest Developments
13.8 Terumo
13.8.1 Terumo Company Information
13.8.2 Terumo Drug Eluting Implant Product Portfolios and Specifications
13.8.3 Terumo Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Terumo Main Business Overview
13.8.5 Terumo Latest Developments
13.9 Biosensors International
13.9.1 Biosensors International Company Information
13.9.2 Biosensors International Drug Eluting Implant Product Portfolios and Specifications
13.9.3 Biosensors International Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Biosensors International Main Business Overview
13.9.5 Biosensors International Latest Developments
13.10 Balton
13.10.1 Balton Company Information
13.10.2 Balton Drug Eluting Implant Product Portfolios and Specifications
13.10.3 Balton Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Balton Main Business Overview
13.10.5 Balton Latest Developments
13.11 AlviMedica Medical Technologies
13.11.1 AlviMedica Medical Technologies Company Information
13.11.2 AlviMedica Medical Technologies Drug Eluting Implant Product Portfolios and Specifications
13.11.3 AlviMedica Medical Technologies Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 AlviMedica Medical Technologies Main Business Overview
13.11.5 AlviMedica Medical Technologies Latest Developments
13.12 Biotronik
13.12.1 Biotronik Company Information
13.12.2 Biotronik Drug Eluting Implant Product Portfolios and Specifications
13.12.3 Biotronik Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Biotronik Main Business Overview
13.12.5 Biotronik Latest Developments
13.13 Shandong JW Medical
13.13.1 Shandong JW Medical Company Information
13.13.2 Shandong JW Medical Drug Eluting Implant Product Portfolios and Specifications
13.13.3 Shandong JW Medical Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Shandong JW Medical Main Business Overview
13.13.5 Shandong JW Medical Latest Developments
13.14 Sino Medical
13.14.1 Sino Medical Company Information
13.14.2 Sino Medical Drug Eluting Implant Product Portfolios and Specifications
13.14.3 Sino Medical Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Sino Medical Main Business Overview
13.14.5 Sino Medical Latest Developments
13.15 Beijing AMSINO
13.15.1 Beijing AMSINO Company Information
13.15.2 Beijing AMSINO Drug Eluting Implant Product Portfolios and Specifications
13.15.3 Beijing AMSINO Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Beijing AMSINO Main Business Overview
13.15.5 Beijing AMSINO Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Eluting Implant Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Drug Eluting Implant by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Drug Eluting Implant by Country/Region, 2018, 2022 & 2029
2.2 Drug Eluting Implant Segment by Type
2.2.1 Rapamycin Eluting Implant
2.2.2 Paclitaxel Eluting Implant
2.2.3 Everolimus Eluting Implant
2.2.4 Others
2.3 Drug Eluting Implant Sales by Type
2.3.1 Global Drug Eluting Implant Sales Market Share by Type (2018-2023)
2.3.2 Global Drug Eluting Implant Revenue and Market Share by Type (2018-2023)
2.3.3 Global Drug Eluting Implant Sale Price by Type (2018-2023)
2.4 Drug Eluting Implant Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Centers
2.4.4 Others
2.5 Drug Eluting Implant Sales by Application
2.5.1 Global Drug Eluting Implant Sale Market Share by Application (2018-2023)
2.5.2 Global Drug Eluting Implant Revenue and Market Share by Application (2018-2023)
2.5.3 Global Drug Eluting Implant Sale Price by Application (2018-2023)
3 GLOBAL DRUG ELUTING IMPLANT BY COMPANY
3.1 Global Drug Eluting Implant Breakdown Data by Company
3.1.1 Global Drug Eluting Implant Annual Sales by Company (2018-2023)
3.1.2 Global Drug Eluting Implant Sales Market Share by Company (2018-2023)
3.2 Global Drug Eluting Implant Annual Revenue by Company (2018-2023)
3.2.1 Global Drug Eluting Implant Revenue by Company (2018-2023)
3.2.2 Global Drug Eluting Implant Revenue Market Share by Company (2018-2023)
3.3 Global Drug Eluting Implant Sale Price by Company
3.4 Key Manufacturers Drug Eluting Implant Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug Eluting Implant Product Location Distribution
3.4.2 Players Drug Eluting Implant Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG ELUTING IMPLANT BY GEOGRAPHIC REGION
4.1 World Historic Drug Eluting Implant Market Size by Geographic Region (2018-2023)
4.1.1 Global Drug Eluting Implant Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Drug Eluting Implant Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Drug Eluting Implant Market Size by Country/Region (2018-2023)
4.2.1 Global Drug Eluting Implant Annual Sales by Country/Region (2018-2023)
4.2.2 Global Drug Eluting Implant Annual Revenue by Country/Region (2018-2023)
4.3 Americas Drug Eluting Implant Sales Growth
4.4 APAC Drug Eluting Implant Sales Growth
4.5 Europe Drug Eluting Implant Sales Growth
4.6 Middle East & Africa Drug Eluting Implant Sales Growth
5 AMERICAS
5.1 Americas Drug Eluting Implant Sales by Country
5.1.1 Americas Drug Eluting Implant Sales by Country (2018-2023)
5.1.2 Americas Drug Eluting Implant Revenue by Country (2018-2023)
5.2 Americas Drug Eluting Implant Sales by Type
5.3 Americas Drug Eluting Implant Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Eluting Implant Sales by Region
6.1.1 APAC Drug Eluting Implant Sales by Region (2018-2023)
6.1.2 APAC Drug Eluting Implant Revenue by Region (2018-2023)
6.2 APAC Drug Eluting Implant Sales by Type
6.3 APAC Drug Eluting Implant Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug Eluting Implant by Country
7.1.1 Europe Drug Eluting Implant Sales by Country (2018-2023)
7.1.2 Europe Drug Eluting Implant Revenue by Country (2018-2023)
7.2 Europe Drug Eluting Implant Sales by Type
7.3 Europe Drug Eluting Implant Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Eluting Implant by Country
8.1.1 Middle East & Africa Drug Eluting Implant Sales by Country (2018-2023)
8.1.2 Middle East & Africa Drug Eluting Implant Revenue by Country (2018-2023)
8.2 Middle East & Africa Drug Eluting Implant Sales by Type
8.3 Middle East & Africa Drug Eluting Implant Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Eluting Implant
10.3 Manufacturing Process Analysis of Drug Eluting Implant
10.4 Industry Chain Structure of Drug Eluting Implant
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug Eluting Implant Distributors
11.3 Drug Eluting Implant Customer
12 WORLD FORECAST REVIEW FOR DRUG ELUTING IMPLANT BY GEOGRAPHIC REGION
12.1 Global Drug Eluting Implant Market Size Forecast by Region
12.1.1 Global Drug Eluting Implant Forecast by Region (2024-2029)
12.1.2 Global Drug Eluting Implant Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug Eluting Implant Forecast by Type
12.7 Global Drug Eluting Implant Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Drug Eluting Implant Product Portfolios and Specifications
13.1.3 Boston Scientific Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Drug Eluting Implant Product Portfolios and Specifications
13.2.3 Medtronic Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Drug Eluting Implant Product Portfolios and Specifications
13.3.3 Abbott Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Lepu Medical
13.4.1 Lepu Medical Company Information
13.4.2 Lepu Medical Drug Eluting Implant Product Portfolios and Specifications
13.4.3 Lepu Medical Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lepu Medical Main Business Overview
13.4.5 Lepu Medical Latest Developments
13.5 B. Braun Melsungen
13.5.1 B. Braun Melsungen Company Information
13.5.2 B. Braun Melsungen Drug Eluting Implant Product Portfolios and Specifications
13.5.3 B. Braun Melsungen Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 B. Braun Melsungen Main Business Overview
13.5.5 B. Braun Melsungen Latest Developments
13.6 MicroPort Scientific
13.6.1 MicroPort Scientific Company Information
13.6.2 MicroPort Scientific Drug Eluting Implant Product Portfolios and Specifications
13.6.3 MicroPort Scientific Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 MicroPort Scientific Main Business Overview
13.6.5 MicroPort Scientific Latest Developments
13.7 Cook Medical
13.7.1 Cook Medical Company Information
13.7.2 Cook Medical Drug Eluting Implant Product Portfolios and Specifications
13.7.3 Cook Medical Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Cook Medical Main Business Overview
13.7.5 Cook Medical Latest Developments
13.8 Terumo
13.8.1 Terumo Company Information
13.8.2 Terumo Drug Eluting Implant Product Portfolios and Specifications
13.8.3 Terumo Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Terumo Main Business Overview
13.8.5 Terumo Latest Developments
13.9 Biosensors International
13.9.1 Biosensors International Company Information
13.9.2 Biosensors International Drug Eluting Implant Product Portfolios and Specifications
13.9.3 Biosensors International Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Biosensors International Main Business Overview
13.9.5 Biosensors International Latest Developments
13.10 Balton
13.10.1 Balton Company Information
13.10.2 Balton Drug Eluting Implant Product Portfolios and Specifications
13.10.3 Balton Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Balton Main Business Overview
13.10.5 Balton Latest Developments
13.11 AlviMedica Medical Technologies
13.11.1 AlviMedica Medical Technologies Company Information
13.11.2 AlviMedica Medical Technologies Drug Eluting Implant Product Portfolios and Specifications
13.11.3 AlviMedica Medical Technologies Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 AlviMedica Medical Technologies Main Business Overview
13.11.5 AlviMedica Medical Technologies Latest Developments
13.12 Biotronik
13.12.1 Biotronik Company Information
13.12.2 Biotronik Drug Eluting Implant Product Portfolios and Specifications
13.12.3 Biotronik Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Biotronik Main Business Overview
13.12.5 Biotronik Latest Developments
13.13 Shandong JW Medical
13.13.1 Shandong JW Medical Company Information
13.13.2 Shandong JW Medical Drug Eluting Implant Product Portfolios and Specifications
13.13.3 Shandong JW Medical Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Shandong JW Medical Main Business Overview
13.13.5 Shandong JW Medical Latest Developments
13.14 Sino Medical
13.14.1 Sino Medical Company Information
13.14.2 Sino Medical Drug Eluting Implant Product Portfolios and Specifications
13.14.3 Sino Medical Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Sino Medical Main Business Overview
13.14.5 Sino Medical Latest Developments
13.15 Beijing AMSINO
13.15.1 Beijing AMSINO Company Information
13.15.2 Beijing AMSINO Drug Eluting Implant Product Portfolios and Specifications
13.15.3 Beijing AMSINO Drug Eluting Implant Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Beijing AMSINO Main Business Overview
13.15.5 Beijing AMSINO Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug Eluting Implant Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Drug Eluting Implant Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Rapamycin Eluting Implant
Table 4. Major Players of Paclitaxel Eluting Implant
Table 5. Major Players of Everolimus Eluting Implant
Table 6. Major Players of Others
Table 7. Global Drug Eluting Implant Sales by Type (2018-2023) & (K Units)
Table 8. Global Drug Eluting Implant Sales Market Share by Type (2018-2023)
Table 9. Global Drug Eluting Implant Revenue by Type (2018-2023) & ($ million)
Table 10. Global Drug Eluting Implant Revenue Market Share by Type (2018-2023)
Table 11. Global Drug Eluting Implant Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Drug Eluting Implant Sales by Application (2018-2023) & (K Units)
Table 13. Global Drug Eluting Implant Sales Market Share by Application (2018-2023)
Table 14. Global Drug Eluting Implant Revenue by Application (2018-2023)
Table 15. Global Drug Eluting Implant Revenue Market Share by Application (2018-2023)
Table 16. Global Drug Eluting Implant Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Drug Eluting Implant Sales by Company (2018-2023) & (K Units)
Table 18. Global Drug Eluting Implant Sales Market Share by Company (2018-2023)
Table 19. Global Drug Eluting Implant Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Drug Eluting Implant Revenue Market Share by Company (2018-2023)
Table 21. Global Drug Eluting Implant Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Drug Eluting Implant Producing Area Distribution and Sales Area
Table 23. Players Drug Eluting Implant Products Offered
Table 24. Drug Eluting Implant Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Drug Eluting Implant Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Drug Eluting Implant Sales Market Share Geographic Region (2018-2023)
Table 29. Global Drug Eluting Implant Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Drug Eluting Implant Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Drug Eluting Implant Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Drug Eluting Implant Sales Market Share by Country/Region (2018-2023)
Table 33. Global Drug Eluting Implant Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Drug Eluting Implant Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Drug Eluting Implant Sales by Country (2018-2023) & (K Units)
Table 36. Americas Drug Eluting Implant Sales Market Share by Country (2018-2023)
Table 37. Americas Drug Eluting Implant Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Drug Eluting Implant Revenue Market Share by Country (2018-2023)
Table 39. Americas Drug Eluting Implant Sales by Type (2018-2023) & (K Units)
Table 40. Americas Drug Eluting Implant Sales by Application (2018-2023) & (K Units)
Table 41. APAC Drug Eluting Implant Sales by Region (2018-2023) & (K Units)
Table 42. APAC Drug Eluting Implant Sales Market Share by Region (2018-2023)
Table 43. APAC Drug Eluting Implant Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Drug Eluting Implant Revenue Market Share by Region (2018-2023)
Table 45. APAC Drug Eluting Implant Sales by Type (2018-2023) & (K Units)
Table 46. APAC Drug Eluting Implant Sales by Application (2018-2023) & (K Units)
Table 47. Europe Drug Eluting Implant Sales by Country (2018-2023) & (K Units)
Table 48. Europe Drug Eluting Implant Sales Market Share by Country (2018-2023)
Table 49. Europe Drug Eluting Implant Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Drug Eluting Implant Revenue Market Share by Country (2018-2023)
Table 51. Europe Drug Eluting Implant Sales by Type (2018-2023) & (K Units)
Table 52. Europe Drug Eluting Implant Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Drug Eluting Implant Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Drug Eluting Implant Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Drug Eluting Implant Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Drug Eluting Implant Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Drug Eluting Implant Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Drug Eluting Implant Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Drug Eluting Implant
Table 60. Key Market Challenges & Risks of Drug Eluting Implant
Table 61. Key Industry Trends of Drug Eluting Implant
Table 62. Drug Eluting Implant Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Drug Eluting Implant Distributors List
Table 65. Drug Eluting Implant Customer List
Table 66. Global Drug Eluting Implant Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Drug Eluting Implant Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Drug Eluting Implant Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Drug Eluting Implant Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Drug Eluting Implant Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Drug Eluting Implant Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Drug Eluting Implant Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Drug Eluting Implant Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Drug Eluting Implant Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Drug Eluting Implant Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Drug Eluting Implant Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Drug Eluting Implant Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Drug Eluting Implant Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Drug Eluting Implant Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Boston Scientific Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 81. Boston Scientific Drug Eluting Implant Product Portfolios and Specifications
Table 82. Boston Scientific Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Boston Scientific Main Business
Table 84. Boston Scientific Latest Developments
Table 85. Medtronic Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 86. Medtronic Drug Eluting Implant Product Portfolios and Specifications
Table 87. Medtronic Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Medtronic Main Business
Table 89. Medtronic Latest Developments
Table 90. Abbott Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 91. Abbott Drug Eluting Implant Product Portfolios and Specifications
Table 92. Abbott Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Abbott Main Business
Table 94. Abbott Latest Developments
Table 95. Lepu Medical Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 96. Lepu Medical Drug Eluting Implant Product Portfolios and Specifications
Table 97. Lepu Medical Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Lepu Medical Main Business
Table 99. Lepu Medical Latest Developments
Table 100. B. Braun Melsungen Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 101. B. Braun Melsungen Drug Eluting Implant Product Portfolios and Specifications
Table 102. B. Braun Melsungen Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. B. Braun Melsungen Main Business
Table 104. B. Braun Melsungen Latest Developments
Table 105. MicroPort Scientific Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 106. MicroPort Scientific Drug Eluting Implant Product Portfolios and Specifications
Table 107. MicroPort Scientific Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. MicroPort Scientific Main Business
Table 109. MicroPort Scientific Latest Developments
Table 110. Cook Medical Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 111. Cook Medical Drug Eluting Implant Product Portfolios and Specifications
Table 112. Cook Medical Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Cook Medical Main Business
Table 114. Cook Medical Latest Developments
Table 115. Terumo Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 116. Terumo Drug Eluting Implant Product Portfolios and Specifications
Table 117. Terumo Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Terumo Main Business
Table 119. Terumo Latest Developments
Table 120. Biosensors International Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 121. Biosensors International Drug Eluting Implant Product Portfolios and Specifications
Table 122. Biosensors International Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Biosensors International Main Business
Table 124. Biosensors International Latest Developments
Table 125. Balton Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 126. Balton Drug Eluting Implant Product Portfolios and Specifications
Table 127. Balton Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Balton Main Business
Table 129. Balton Latest Developments
Table 130. AlviMedica Medical Technologies Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 131. AlviMedica Medical Technologies Drug Eluting Implant Product Portfolios and Specifications
Table 132. AlviMedica Medical Technologies Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. AlviMedica Medical Technologies Main Business
Table 134. AlviMedica Medical Technologies Latest Developments
Table 135. Biotronik Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 136. Biotronik Drug Eluting Implant Product Portfolios and Specifications
Table 137. Biotronik Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Biotronik Main Business
Table 139. Biotronik Latest Developments
Table 140. Shandong JW Medical Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 141. Shandong JW Medical Drug Eluting Implant Product Portfolios and Specifications
Table 142. Shandong JW Medical Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Shandong JW Medical Main Business
Table 144. Shandong JW Medical Latest Developments
Table 145. Sino Medical Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 146. Sino Medical Drug Eluting Implant Product Portfolios and Specifications
Table 147. Sino Medical Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Sino Medical Main Business
Table 149. Sino Medical Latest Developments
Table 150. Beijing AMSINO Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 151. Beijing AMSINO Drug Eluting Implant Product Portfolios and Specifications
Table 152. Beijing AMSINO Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Beijing AMSINO Main Business
Table 154. Beijing AMSINO Latest Developments
Table 1. Drug Eluting Implant Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Drug Eluting Implant Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Rapamycin Eluting Implant
Table 4. Major Players of Paclitaxel Eluting Implant
Table 5. Major Players of Everolimus Eluting Implant
Table 6. Major Players of Others
Table 7. Global Drug Eluting Implant Sales by Type (2018-2023) & (K Units)
Table 8. Global Drug Eluting Implant Sales Market Share by Type (2018-2023)
Table 9. Global Drug Eluting Implant Revenue by Type (2018-2023) & ($ million)
Table 10. Global Drug Eluting Implant Revenue Market Share by Type (2018-2023)
Table 11. Global Drug Eluting Implant Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Drug Eluting Implant Sales by Application (2018-2023) & (K Units)
Table 13. Global Drug Eluting Implant Sales Market Share by Application (2018-2023)
Table 14. Global Drug Eluting Implant Revenue by Application (2018-2023)
Table 15. Global Drug Eluting Implant Revenue Market Share by Application (2018-2023)
Table 16. Global Drug Eluting Implant Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Drug Eluting Implant Sales by Company (2018-2023) & (K Units)
Table 18. Global Drug Eluting Implant Sales Market Share by Company (2018-2023)
Table 19. Global Drug Eluting Implant Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Drug Eluting Implant Revenue Market Share by Company (2018-2023)
Table 21. Global Drug Eluting Implant Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Drug Eluting Implant Producing Area Distribution and Sales Area
Table 23. Players Drug Eluting Implant Products Offered
Table 24. Drug Eluting Implant Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Drug Eluting Implant Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Drug Eluting Implant Sales Market Share Geographic Region (2018-2023)
Table 29. Global Drug Eluting Implant Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Drug Eluting Implant Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Drug Eluting Implant Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Drug Eluting Implant Sales Market Share by Country/Region (2018-2023)
Table 33. Global Drug Eluting Implant Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Drug Eluting Implant Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Drug Eluting Implant Sales by Country (2018-2023) & (K Units)
Table 36. Americas Drug Eluting Implant Sales Market Share by Country (2018-2023)
Table 37. Americas Drug Eluting Implant Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Drug Eluting Implant Revenue Market Share by Country (2018-2023)
Table 39. Americas Drug Eluting Implant Sales by Type (2018-2023) & (K Units)
Table 40. Americas Drug Eluting Implant Sales by Application (2018-2023) & (K Units)
Table 41. APAC Drug Eluting Implant Sales by Region (2018-2023) & (K Units)
Table 42. APAC Drug Eluting Implant Sales Market Share by Region (2018-2023)
Table 43. APAC Drug Eluting Implant Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Drug Eluting Implant Revenue Market Share by Region (2018-2023)
Table 45. APAC Drug Eluting Implant Sales by Type (2018-2023) & (K Units)
Table 46. APAC Drug Eluting Implant Sales by Application (2018-2023) & (K Units)
Table 47. Europe Drug Eluting Implant Sales by Country (2018-2023) & (K Units)
Table 48. Europe Drug Eluting Implant Sales Market Share by Country (2018-2023)
Table 49. Europe Drug Eluting Implant Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Drug Eluting Implant Revenue Market Share by Country (2018-2023)
Table 51. Europe Drug Eluting Implant Sales by Type (2018-2023) & (K Units)
Table 52. Europe Drug Eluting Implant Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Drug Eluting Implant Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Drug Eluting Implant Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Drug Eluting Implant Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Drug Eluting Implant Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Drug Eluting Implant Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Drug Eluting Implant Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Drug Eluting Implant
Table 60. Key Market Challenges & Risks of Drug Eluting Implant
Table 61. Key Industry Trends of Drug Eluting Implant
Table 62. Drug Eluting Implant Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Drug Eluting Implant Distributors List
Table 65. Drug Eluting Implant Customer List
Table 66. Global Drug Eluting Implant Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Drug Eluting Implant Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Drug Eluting Implant Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Drug Eluting Implant Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Drug Eluting Implant Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Drug Eluting Implant Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Drug Eluting Implant Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Drug Eluting Implant Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Drug Eluting Implant Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Drug Eluting Implant Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Drug Eluting Implant Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Drug Eluting Implant Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Drug Eluting Implant Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Drug Eluting Implant Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Boston Scientific Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 81. Boston Scientific Drug Eluting Implant Product Portfolios and Specifications
Table 82. Boston Scientific Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Boston Scientific Main Business
Table 84. Boston Scientific Latest Developments
Table 85. Medtronic Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 86. Medtronic Drug Eluting Implant Product Portfolios and Specifications
Table 87. Medtronic Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Medtronic Main Business
Table 89. Medtronic Latest Developments
Table 90. Abbott Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 91. Abbott Drug Eluting Implant Product Portfolios and Specifications
Table 92. Abbott Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Abbott Main Business
Table 94. Abbott Latest Developments
Table 95. Lepu Medical Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 96. Lepu Medical Drug Eluting Implant Product Portfolios and Specifications
Table 97. Lepu Medical Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Lepu Medical Main Business
Table 99. Lepu Medical Latest Developments
Table 100. B. Braun Melsungen Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 101. B. Braun Melsungen Drug Eluting Implant Product Portfolios and Specifications
Table 102. B. Braun Melsungen Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. B. Braun Melsungen Main Business
Table 104. B. Braun Melsungen Latest Developments
Table 105. MicroPort Scientific Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 106. MicroPort Scientific Drug Eluting Implant Product Portfolios and Specifications
Table 107. MicroPort Scientific Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. MicroPort Scientific Main Business
Table 109. MicroPort Scientific Latest Developments
Table 110. Cook Medical Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 111. Cook Medical Drug Eluting Implant Product Portfolios and Specifications
Table 112. Cook Medical Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Cook Medical Main Business
Table 114. Cook Medical Latest Developments
Table 115. Terumo Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 116. Terumo Drug Eluting Implant Product Portfolios and Specifications
Table 117. Terumo Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Terumo Main Business
Table 119. Terumo Latest Developments
Table 120. Biosensors International Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 121. Biosensors International Drug Eluting Implant Product Portfolios and Specifications
Table 122. Biosensors International Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Biosensors International Main Business
Table 124. Biosensors International Latest Developments
Table 125. Balton Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 126. Balton Drug Eluting Implant Product Portfolios and Specifications
Table 127. Balton Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Balton Main Business
Table 129. Balton Latest Developments
Table 130. AlviMedica Medical Technologies Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 131. AlviMedica Medical Technologies Drug Eluting Implant Product Portfolios and Specifications
Table 132. AlviMedica Medical Technologies Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. AlviMedica Medical Technologies Main Business
Table 134. AlviMedica Medical Technologies Latest Developments
Table 135. Biotronik Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 136. Biotronik Drug Eluting Implant Product Portfolios and Specifications
Table 137. Biotronik Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Biotronik Main Business
Table 139. Biotronik Latest Developments
Table 140. Shandong JW Medical Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 141. Shandong JW Medical Drug Eluting Implant Product Portfolios and Specifications
Table 142. Shandong JW Medical Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Shandong JW Medical Main Business
Table 144. Shandong JW Medical Latest Developments
Table 145. Sino Medical Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 146. Sino Medical Drug Eluting Implant Product Portfolios and Specifications
Table 147. Sino Medical Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Sino Medical Main Business
Table 149. Sino Medical Latest Developments
Table 150. Beijing AMSINO Basic Information, Drug Eluting Implant Manufacturing Base, Sales Area and Its Competitors
Table 151. Beijing AMSINO Drug Eluting Implant Product Portfolios and Specifications
Table 152. Beijing AMSINO Drug Eluting Implant Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Beijing AMSINO Main Business
Table 154. Beijing AMSINO Latest Developments
LIST OF FIGURES
Figure 1. Picture of Drug Eluting Implant
Figure 2. Drug Eluting Implant Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug Eluting Implant Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Drug Eluting Implant Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Drug Eluting Implant Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Rapamycin Eluting Implant
Figure 10. Product Picture of Paclitaxel Eluting Implant
Figure 11. Product Picture of Everolimus Eluting Implant
Figure 12. Product Picture of Others
Figure 13. Global Drug Eluting Implant Sales Market Share by Type in 2022
Figure 14. Global Drug Eluting Implant Revenue Market Share by Type (2018-2023)
Figure 15. Drug Eluting Implant Consumed in Hospitals
Figure 16. Global Drug Eluting Implant Market: Hospitals (2018-2023) & (K Units)
Figure 17. Drug Eluting Implant Consumed in Clinics
Figure 18. Global Drug Eluting Implant Market: Clinics (2018-2023) & (K Units)
Figure 19. Drug Eluting Implant Consumed in Ambulatory Surgical Centers
Figure 20. Global Drug Eluting Implant Market: Ambulatory Surgical Centers (2018-2023) & (K Units)
Figure 21. Drug Eluting Implant Consumed in Others
Figure 22. Global Drug Eluting Implant Market: Others (2018-2023) & (K Units)
Figure 23. Global Drug Eluting Implant Sales Market Share by Application (2022)
Figure 24. Global Drug Eluting Implant Revenue Market Share by Application in 2022
Figure 25. Drug Eluting Implant Sales Market by Company in 2022 (K Units)
Figure 26. Global Drug Eluting Implant Sales Market Share by Company in 2022
Figure 27. Drug Eluting Implant Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Drug Eluting Implant Revenue Market Share by Company in 2022
Figure 29. Global Drug Eluting Implant Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Drug Eluting Implant Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Drug Eluting Implant Sales 2018-2023 (K Units)
Figure 32. Americas Drug Eluting Implant Revenue 2018-2023 ($ Millions)
Figure 33. APAC Drug Eluting Implant Sales 2018-2023 (K Units)
Figure 34. APAC Drug Eluting Implant Revenue 2018-2023 ($ Millions)
Figure 35. Europe Drug Eluting Implant Sales 2018-2023 (K Units)
Figure 36. Europe Drug Eluting Implant Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Drug Eluting Implant Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Drug Eluting Implant Revenue 2018-2023 ($ Millions)
Figure 39. Americas Drug Eluting Implant Sales Market Share by Country in 2022
Figure 40. Americas Drug Eluting Implant Revenue Market Share by Country in 2022
Figure 41. Americas Drug Eluting Implant Sales Market Share by Type (2018-2023)
Figure 42. Americas Drug Eluting Implant Sales Market Share by Application (2018-2023)
Figure 43. United States Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Drug Eluting Implant Sales Market Share by Region in 2022
Figure 48. APAC Drug Eluting Implant Revenue Market Share by Regions in 2022
Figure 49. APAC Drug Eluting Implant Sales Market Share by Type (2018-2023)
Figure 50. APAC Drug Eluting Implant Sales Market Share by Application (2018-2023)
Figure 51. China Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Drug Eluting Implant Sales Market Share by Country in 2022
Figure 59. Europe Drug Eluting Implant Revenue Market Share by Country in 2022
Figure 60. Europe Drug Eluting Implant Sales Market Share by Type (2018-2023)
Figure 61. Europe Drug Eluting Implant Sales Market Share by Application (2018-2023)
Figure 62. Germany Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Drug Eluting Implant Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Drug Eluting Implant Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Drug Eluting Implant Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Drug Eluting Implant Sales Market Share by Application (2018-2023)
Figure 71. Egypt Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Drug Eluting Implant in 2022
Figure 77. Manufacturing Process Analysis of Drug Eluting Implant
Figure 78. Industry Chain Structure of Drug Eluting Implant
Figure 79. Channels of Distribution
Figure 80. Global Drug Eluting Implant Sales Market Forecast by Region (2024-2029)
Figure 81. Global Drug Eluting Implant Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Drug Eluting Implant Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Drug Eluting Implant Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Drug Eluting Implant Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Drug Eluting Implant Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Drug Eluting Implant
Figure 2. Drug Eluting Implant Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug Eluting Implant Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Drug Eluting Implant Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Drug Eluting Implant Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Rapamycin Eluting Implant
Figure 10. Product Picture of Paclitaxel Eluting Implant
Figure 11. Product Picture of Everolimus Eluting Implant
Figure 12. Product Picture of Others
Figure 13. Global Drug Eluting Implant Sales Market Share by Type in 2022
Figure 14. Global Drug Eluting Implant Revenue Market Share by Type (2018-2023)
Figure 15. Drug Eluting Implant Consumed in Hospitals
Figure 16. Global Drug Eluting Implant Market: Hospitals (2018-2023) & (K Units)
Figure 17. Drug Eluting Implant Consumed in Clinics
Figure 18. Global Drug Eluting Implant Market: Clinics (2018-2023) & (K Units)
Figure 19. Drug Eluting Implant Consumed in Ambulatory Surgical Centers
Figure 20. Global Drug Eluting Implant Market: Ambulatory Surgical Centers (2018-2023) & (K Units)
Figure 21. Drug Eluting Implant Consumed in Others
Figure 22. Global Drug Eluting Implant Market: Others (2018-2023) & (K Units)
Figure 23. Global Drug Eluting Implant Sales Market Share by Application (2022)
Figure 24. Global Drug Eluting Implant Revenue Market Share by Application in 2022
Figure 25. Drug Eluting Implant Sales Market by Company in 2022 (K Units)
Figure 26. Global Drug Eluting Implant Sales Market Share by Company in 2022
Figure 27. Drug Eluting Implant Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Drug Eluting Implant Revenue Market Share by Company in 2022
Figure 29. Global Drug Eluting Implant Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Drug Eluting Implant Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Drug Eluting Implant Sales 2018-2023 (K Units)
Figure 32. Americas Drug Eluting Implant Revenue 2018-2023 ($ Millions)
Figure 33. APAC Drug Eluting Implant Sales 2018-2023 (K Units)
Figure 34. APAC Drug Eluting Implant Revenue 2018-2023 ($ Millions)
Figure 35. Europe Drug Eluting Implant Sales 2018-2023 (K Units)
Figure 36. Europe Drug Eluting Implant Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Drug Eluting Implant Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Drug Eluting Implant Revenue 2018-2023 ($ Millions)
Figure 39. Americas Drug Eluting Implant Sales Market Share by Country in 2022
Figure 40. Americas Drug Eluting Implant Revenue Market Share by Country in 2022
Figure 41. Americas Drug Eluting Implant Sales Market Share by Type (2018-2023)
Figure 42. Americas Drug Eluting Implant Sales Market Share by Application (2018-2023)
Figure 43. United States Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Drug Eluting Implant Sales Market Share by Region in 2022
Figure 48. APAC Drug Eluting Implant Revenue Market Share by Regions in 2022
Figure 49. APAC Drug Eluting Implant Sales Market Share by Type (2018-2023)
Figure 50. APAC Drug Eluting Implant Sales Market Share by Application (2018-2023)
Figure 51. China Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Drug Eluting Implant Sales Market Share by Country in 2022
Figure 59. Europe Drug Eluting Implant Revenue Market Share by Country in 2022
Figure 60. Europe Drug Eluting Implant Sales Market Share by Type (2018-2023)
Figure 61. Europe Drug Eluting Implant Sales Market Share by Application (2018-2023)
Figure 62. Germany Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Drug Eluting Implant Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Drug Eluting Implant Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Drug Eluting Implant Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Drug Eluting Implant Sales Market Share by Application (2018-2023)
Figure 71. Egypt Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Drug Eluting Implant Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Drug Eluting Implant in 2022
Figure 77. Manufacturing Process Analysis of Drug Eluting Implant
Figure 78. Industry Chain Structure of Drug Eluting Implant
Figure 79. Channels of Distribution
Figure 80. Global Drug Eluting Implant Sales Market Forecast by Region (2024-2029)
Figure 81. Global Drug Eluting Implant Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Drug Eluting Implant Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Drug Eluting Implant Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Drug Eluting Implant Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Drug Eluting Implant Revenue Market Share Forecast by Application (2024-2029)
